Mupirocin
As of the edition of 20 October 2026, Mupirocin is a small molecule: marketed, first approved in 1987 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1991
- Kind
- Small molecule
- Brand name
- Bactroban
- First approved
- 31 December 1987 (US)
- Approvals on record
- 10 in 5 regions
- Holder of the most recent approval
- Padagis; 3 holders in all
- Registered trials
- 39, 2 stopped early
- Disease areas
- Infections; Skin and connective tissue; Digestive system; Inherited and neonatal; Lungs and airways; Cancer
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 12 | 10 | 0 | 0 |
| Phase 1 | 3 | 1 | 2 | 0 |
| Phase 2 | 8 | 5 | 2 | 1 |
| Phase 3 | 9 | 5 | 1 | 1 |
| Phase 4 | 7 | 6 | 0 | 0 |
| All trials | 39 |